Position in NVS
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$5,641
+$142 QoQ
Shares Held
36
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,562
of 1,603 holders
Holding Since
Dec 2023
10 quarters on record
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Main Street Group, LTD holds $2,042,882 across 10 Drug Manufacturers - General names. NVS ranks #9 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
3,455 | $877,465 | |
| 2 | ABBV |
AbbVie Inc.
|
2,780 | $699,557 | |
| 3 | LLY |
ELI LILLY & Co
|
142 | $170,319 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
818 | $103,346 | |
| 5 | AMGN |
Amgen Inc
|
245 | $88,718 | |
| 6 | MRK |
Merck & Co., Inc.
|
505 | $64,892 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
375 | $21,607 | |
| 8 | PFE |
Pfizer Inc
|
362 | $8,716 |
All Filings in NVS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,641 | 36 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $5,499 | 36 | Shares | Sole | 2026-05-06 | |
| 2025-09-30 | $4,616 | 36 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $4,356 | 36 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $10,925 | 98 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $9,536 | 98 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $11,271 | 98 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,600 | 62 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $5,997 | 62 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,260 | 62 | Shares | Sole | 2024-02-15 | |
| No filing history on record for this holder in this stock. | ||||||